MS patients eager for arrival of new drug

A new FDA approved pill-based drug, Ampyra, claims to improve MS symptoms and aid MS sufferers with walking and other nerve related symptoms.  This is in contrast to existing Antifueron injections which have been traditionally used to suppress the progression of MS. 

 It is not clear how Ampyra reacts with Lyme-induced MS.  If anyone has any experience in this area please post your experiences. 

Excerpted from LoHUD.COM ( Posted: 2/02/2010 )

The 48-year-old Putnam Valley mom has multiple sclerosis, or MS, an incurable, often disabling disease of the central nervous system in which the flow of information within the brain and between the brain and body are interrupted. She has problems with balance and vision and lacks the sensitivity to feel heat. 

 “Everyone else just walks without thinking about it. If I’m having a bad day, the foot just won’t go. … I have to say, ‘C’mon foot, let’s go!'”


 In the past few years, the disease has stripped her of the active life she enjoyed rollerblading and hiking with her two sons.

 But this week, news about a drug made by Hawthorne-based biotech company Acorda Therapeutics piqued her interest.

 The drug, called Ampyra, also known as fampridine-SR, is the first pill to treat the symptoms of MS and improve walking speed, researchers say.

The drug and the local company have grabbed national headlines since the Food and Drug Adminstration approved it for use on Jan. 22.

More at:

~ by Rob on February 2, 2010.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: